US2022259573A1PendingUtilityA1
Method for producing a modified bacteriophage without genome modification
Est. expiryJul 18, 2039(~13 yrs left)· nominal 20-yr term from priority
A23B 2/783A23B 70/10C12N 7/00C12Q 1/66C12N 7/02A61K 35/76C12N 2795/10132C12N 15/00C12N 2795/10151C12N 2795/10121A61P 31/04C12N 15/01C12N 2795/10122C07K 14/005
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a method for producing a modified bacteriophage in a cell-free expression system wherein the expression of at least one gene of interest is suppressed by a molecule specifically inhibiting its expression. The invention further relates to a composition and a kit for producing a modified bacteriophage. Moreover, the invention relates to a bacteriophage which is not modified on the genomic level but on the proteomic level and its use for therapy, for diagnostic and detection assays.
Claims
exact text as granted — not AI-modified1 . Method for producing a modified bacteriophage in a cell-free expression system comprising the steps of:
contacting a cell lysate of a microorganism with a genome of the bacteriophage, suppressing expression of at least one gene of interest encoded by the genome of the bacteriophage by adding a molecule specifically inhibiting the expression of the endogenous version of the at least one gene of interest.
2 . Method according to claim 1 , wherein the method further comprises the step of
expression of a modified version of the at least one gene of interest by adding a molecule encoding a modified version of the gene of interest.
3 . Method according to claim 1 or 2 , wherein the method further comprises the step of
adding a modified bacteriophage protein encoded by a modified version of the at least one gene of interest.
4 . Method according to any one of the preceding claims, wherein the gene of interest is an essential gene or a non-essential gene.
5 . Method according to any one of the preceding claims, wherein the genome of the bacteriophage is not modified.
6 . Method according to any one of the preceding claims, wherein the gene of interest encodes a capsid protein or a tail fiber protein of the bacteriophage, preferably wherein the gene of interest encodes a highly immunogeneic outer capsid protein (HOC).
7 . Method according to any one of the preceding claims, wherein the modified bacteriophage protein comprises a modification selected from the group consisting of an affinity tag, a detection marker, a protein for the improvement of the bacteriophage or mutation or combinations thereof
8 . Method according to any one of the preceding claims, wherein the bacteriophage is a bacteriophage of the Myoviridae family, preferably of the Tevenvirinae subfamily, even more preferably a T4 virus, most preferably the bacteriophage is Escherichia virus T4.
9 . Composition for producing of a bacteriophage comprising:
a cell lysate of a microorganism, a genome of the bacteriophage, a molecule specifically inhibiting the expression of the endogenous version of the gene of interest, optionally a molecule encoding a modified version of the gene of interest, and optionally a modified bacteriophage protein encoded by a modified version of the at least one gene of interest.
10 . Kit for producing a bacteriophage comprising:
a cell lysate of a microorganism, a genome of the bacteriophage, a molecule specifically inhibiting the expression of the endogenous version of the gene of interest, optionally a molecule encoding a modified version of the gene of interest, and/or optionally a modified bacteriophage protein encoded by a modified version of the at least one gene of interest.
11 . Bacteriophage comprising
a genome which is not modified, modified bacteriophage protein.
12 . Bacteriophage obtained by the method according to claims 1 to 8 .
13 . Bacteriophage according to claims 11 and 12 for use as a medicament.
14 . Bacteriophage according to claims 11 and 12 for used in the treatment of a bacterial infection in a subject.
15 . Use of the bacteriophage according to claims 11 and 12 for avoiding bacterial growth in food or beverage.
16 . Use of the bacteriophage of claims 11 and 12 for detecting specific microorganisms.Join the waitlist — get patent alerts
Track US2022259573A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.